CSS
ALBO

Cubist Systematic Strategies’s Albireo Pharma Inc ALBO Stock Holding History

Cubist Systematic Strategies’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,640
Closed -$187K – 4768
2022
Q4 		$187K Buy
8,640
+4,930
+133% +$104K ﹤0.01% 3614
2022
Q3 		$72K Buy
+3,710
New +$76.7K ﹤0.01% 4074
2022
Q2 		– Sell
-10,975
Closed -$327K – 4707
2022
Q1 		$327K Buy
10,975
+10,006
+1,033% +$293K ﹤0.01% 2791
2021
Q4 		$23K Buy
+969
New +$25.8K ﹤0.01% 3370
2020
Q4 		– Sell
-7,129
Closed -$238K – 2770
2020
Q3 		$238K Buy
7,129
+7,103
+27,319% +$207K ﹤0.01% 2070
2020
Q2 		$1K Sell
26
-8,229
-100% -$194K ﹤0.01% 2368
2020
Q1 		$135K Buy
+8,255
New +$182K ﹤0.01% 1838
2019
Q4 		– Sell
-415
Closed -$8K – 2602
2019
Q3 		$8K Sell
415
-344
-45% -$8.9K ﹤0.01% 2157
2019
Q2 		$24K Buy
+759
New +$25.4K ﹤0.01% 2378

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cubist Systematic Strategies's ALBO Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 8,640 shares — an estimated $187K sold.

Cubist Systematic Strategies first reported a position in ALBO in Q2 2019 and held it in 9 quarters. The position peaked at $327K in Q1 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Cubist Systematic Strategies reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 8,640 Albireo Pharma Inc shares in Q1 2023, an estimated $187K.
  • Cubist Systematic Strategies first reported a position in Albireo Pharma Inc in Q2 2019 and held it in 9 quarters.
  • Cubist Systematic Strategies's Albireo Pharma Inc position peaked at $327K in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.